chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was told to report my breakout covid infection to vaers.  I had a long covid infection starting on  June 23,2020. I had a Johnson and Johnson vaccination on March 19, 2021. I had a Moderna booster on Nov 18, 2021. I caught covid19 ahmgain in December 2021 and had a positive covid pcr trst on Dec 22,2021.
Allergic reaction. Broke out in hives over body. Referred to allergy specialist. Subsided after cocktail of medications received from urgent care.
No symptomatic AEs reported; Inbound call from HCP reporting a patient received a 3rd dose of PROQUAD inadvertently on 08/23/2022 after the second dose was administered. on 12/01/2021. No symptomatic AEs reported. No additional AE details or PQC.; This spontaneous report was received from a Nurse referring to a 4-year-old female patient. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided. Concomitant therapies included diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX).     On 01-DEC-2021, the patient was vaccinated with the second dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength, dose, route of administration, anatomical location, lot # and expiration date were not reported).     On 23-AUG-2022, the patient received inadvertently a third dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 mL, by subcutaneous route, in the left thigh, lot # W007745 with expiration date on 04-SEP-2023, after the second dose (extra dose administered). Patient was doing fine and there was no side effects (no adverse event). The error was caught the same vaccination day and was informed to the provider, office manager, pharmaceutical companies and patient's mother. Vaccines were not updated into the local immunization information system.
Been freaking out; I can breath but can't catch that last breath IN and been yawning a lot since thursday; I can breath but can't catch that last breath IN and been yawning a lot since thursday; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Been freaking out), DYSPNOEA (since thursday), and YAWNING (since thursday) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified and Asthma.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Been freaking out), DYSPNOEA (since thursday) and YAWNING (since thursday). At the time of the report, FEELING ABNORMAL (Been freaking out), DYSPNOEA (since thursday) and YAWNING (since thursday) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       The concomitant history was not reported. The treatment history was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: Follow-up information received on 17-AUG-2021 contains significant information. Medical history information is reported. On 18-Aug-2021: Follow-up information received on 17-AUG-2021 contains significant information. Event information that the yawning is still ongoing. On 18-Aug-2021: Follow-up information received on 17-AUG-2021 contains significant information. Another Medical history Asthma is reported.
Dev. 1st symptoms on 10/8 - (L) eye pain. Developed Bell's Palsy on 10/10/10 with (L) sided facial paralysis, numbness, (L) eye pain and  (L) ear pain. Seen at ER and private MD - Rx'ed with Medrol dose pack, VALTREX. Partially resolved at 11 days ago.
09July97 pt recv 1 dose vax. December97 pt devel varicella. Another pt was reported from this source. (WAES97121379)
feels viral; night of fever which breaks; painful bouts of muscle pain in my hip and back; but not pain free; Muscular back pain; This case was reported by a consumer and described the occurrence of viral infection in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced viral infection, fever, muscle pain, pain and muscular back pain. On an unknown date, the outcome of the viral infection and muscular back pain were unknown and the outcome of the fever, muscle pain and pain were not recovered/not resolved.   It was unknown if the reporter considered the viral infection, fever, muscle pain, pain and muscular back pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per the vaccine indication. Since having the second dose of shingrix the patient had very painful bouts of muscle pain in the hip and back which culminated into a night of fever which broke and the next day was better but not pain free. The patient also felt viral. The patient stated that this has been going on for three weeks. The patient inquired to the pharmacist if he/she had heard of it earlier since the patient had never had this before. The pharmacist laughed and stated it was not related.
Patient had anaphylaxis several minutes following injection. Received oxygen, benadryl and Epi. He was monitored following.
Engerix-B pediatric dose to adult patient; Adult patient received a pediatric dose; This case was reported by a nurse and described the occurrence of underdose in a 26-year-old male patient who received HBV (Engerix B pediatric) (batch number MY3RA, expiry date 21st September 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The adult patient received a pediatric dose of Engerix-B, which led to underdose and adult use of a child product. The vaccine administration facility is the same as primary reporter. The reporter consented to follow up.
Pt recvd 3 doses of Engerix-B & titer report dated 13JAN92 indicated pt did not respond;
Post first vax no untoward effects. Post second dose, one week later, experienced bilateral knee pain. Treatment included ibuprofen, and Lymerix was discontinued.
This spontaneous pregnancy report as received from a registered nurse, for GARDASIL, Pregnancy Registry product, refers to a 14 years old female patient. The patient's history of previous pregnancies and live births is not known. The patient was vaccinated with dose 1 GARDASIL on 04-AUG-2011. On 22-DEC-2011, the patient was vaccinated with the second dose of GARDASIL. Subsequently, the patient became pregnant with an LMP of 15-JUN-2012 and an EDD of 22-MAR-2013. Initial exposure to GARDASIL was at 7 weeks. On 07-AUG-2012, the patient was vaccinated with the third dose of GARDASIL (lot # 670049/1171AA). Concomitant medications included: vitamins (unspecified) (vitamins (unspecified)). Additional information has been requested.
Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and FATIGUE (Fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). On 30-Mar-2021, CHILLS (Chills) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported by the reporter  No treatment reported by the reporter
Red rash on the back, chest, elbow, and forearm; temperature of 101,3°F; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of RASH ERYTHEMATOUS (Red rash on the back, chest, elbow, and forearm) and PYREXIA (temperature of 101,3°F) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on the back, chest, elbow, and forearm) and PYREXIA (temperature of 101,3°F). On 17-Apr-2021, PYREXIA (temperature of 101,3°F) had resolved. At the time of the report, RASH ERYTHEMATOUS (Red rash on the back, chest, elbow, and forearm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient received the Johnson and Johnson shot on 05/24/2021 and then was give the Moderna shot on 9/9/21. No adverse events reported
flu symptoms. Pt received Covid J&J 1100 10MAR2021. Pt started having HA, fever, chills started midnight. Pt denies coughs, nausea, chest pain, respiratory problems, abd pain. History:  pt received J&J COVID-19 vaccine around 10am and woke up around midnight with shakes/chills and mild non-thunderclap frontal headache with mild body ache, here for eval.  Had work-out earlier and not sure if body ache is from work-out, per pt.  denies any recent illness/injury or symptoms prior to the COVID-19 vaccine this morning.  No visual deterioration, sore throat, cough, SOB, vomit/diarrhea, rash, sick contact, recent COVID-19 hotspot visit, co-morbidities, use of any meds, or chance of pregnancy, per pt.
Patient received his second dose of Pfizer COVID Vaccine on 13 Apr 2021 at about 9:30 AM. That afternoon, he began to experience chills, body aches and back pain. Later that night, unable to sleep, he began to experience visual hallucinations, to include a demon to his immediate left, a candle in his far left periphery, shackles, the room going dark and feeling like he was stuck in a time loop. In addition he experienced auditory hallucinations, to include a demon yelling and people whispering.  He took ibuprofen that afternoon for his chills. No known psychiatric history or drug use. He denied suicidal ideation. Has a history of back pain for which he has been seeing physical therapy for several months. Enjoys his job with no identifiable unique stressors.  Work up in the Emergency Department included CBC, electrolytes, Urine drug screen, ETOH, procalcitonin and urinalysis. All were normal, with the exception of an elevated neutrophil count and low lymphocyte count. Head CT was normal as well.
Generalized Hives Facial swelling Myalgias started approx 4-5 hours after vaccine, intermittent for 4 weeks with hives/myalgias
Starting in mid-October she experienced abdominal pain. Admitted for stroke on 11/5/2021 Superior mesenteric artery occlusion on 11/9/2021 left common femoral artery occlusion on 11/9/2021 death on 11/12/2021
Patient received first dose of Moderna Covid Vaccine Lot:026c21a and had hives 7-14 days after initial dose. Second dose was a normal unreactive reaction.
Client had rash around immunization site LALT few (approx 6) near IM site interior left upper leg and posterior right thigh and abdomen area, very scattered. Stated more rash on 04/27 + 04/28/02 but resolving used lotion. Low grade fever < 100.
Very strong pain at the back of her neck; Fell down to the floor; Funny sensation in her neck; Felt the brain moving side to side; Felt very weak; Head squeezing; This spontaneous case was received on 15-Oct-2021 from other healthcare professional via Med Communications (reference number: SEQW21-03956) and concerned an 89-year-old, female patient.  The patient had no relevant medical history and was not taking any concomitant medications. The patient was vaccinated with Moderna COVID-19 vaccine in Aug-2021.    On 07-Oct-2021, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; dose: 0.5 ml, route of administration: intramuscular and anatomical location: deltoid) for influenza prophylaxis. The batch number reported was 312841 and expiry date 19-May-2022.  On the same day, 15 minutes after receiving Fluad Quadrivalent, the patient experienced funny sensation in her neck, very strong pain at the back of her neck, felt the brain moving side to side and afterwards she felt very weak and fell on the floor.  On an unspecified date in Oct-2021, after one week, she still felt the head was squeezing. She was treated with Advil (ibuprofen).   At the time of initial reporting on 15-Oct-2021, the patient had not recovered from the events since she stated that she was not better.  The reporter did not provide causality assessment.   The case was assessed as non-serious.  Company comment: A 89-year-old, female patient experienced funny sensation in neck, very strong pain at the back of the neck, head discomfort, asthenia and fall, fifteen minutes after vaccination with the suspect product Fluad Quadrivalent. Approximately one week after vaccination, the patient felt tension headache (reported as head squeezing). The patient had no relevant medical history and was not taking any concomitant medications. Information regarding diagnostic data was not provided. Causal role of the suspect vaccine is assessed as possibly related for all events, due to biological and chronological plausibility, except for the event fall for which causality is unassessable.; Sender's Comments: A 89-year-old, female patient experienced funny sensation in neck, very strong pain at the back of the neck, head discomfort, asthenia and fall fifteen minutes after vaccination with the suspect product Fluad Quadrivalent. Approximately one week after vaccination, the patient felt tension headache (reported as head squeezing). The patient had no relevant medical history and was not taking any concomitant medications. Information regarding diagnostic data was not provided. Causal role of the suspect vaccine is assessed as possibly related for all events, due to biological and chronological plausibility, except for the event fall for which causality is unassessable.
immediate itching at the site of injection within the first 15 minutes. Rash occurred in the next 24 hours on arms, shoulders, inside of knees and ankles. Swelling and itching at injection site.
I experienced itching and tingling in my mouth, throat and ears. A red rash could be seen on the roof of my mouth down my throat. This has happened three times since getting the shot and I have never experienced this before. Symptoms resolved with benadryl.
Mild asthma flare and mild itch on face 60-90 minutes after injection. Symptoms resolved with no medical treatment required.
An entire .3ml bottle of Covid vaccine was drawn and put in the 2ml sodium chloride diluent. A .3ml covid dose was drawn and administered to the patient. This was the patients 3rd dose
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. No previous drug reactions or allergies were reported. On 20-FEB-2018 the patient was vaccinated with one dose improperly stored PROQUAD (lot # N010865, expiry date: 01-OCT-2018) one dose (dosing details were not reported) which was reconstituted with properly stored sterile diluent (lot # M014034, expiry date: 20-NOV-2018) or (lot # N015631, expiry date: 18-MAR-2019 (also reported 18-OCT-2019)) for prophylaxis at a temperature of 15 degree Fahrenheit  to 46 degree Fahrenheit for 40 minutes time frame, also 6 degree Fahrenheit to 14 degree Fahrenheit for 30 minutes (incorrect product stored). No adverse effects reported. No previous temperature excursion reported. There was a digital data logger involved. No product quality complaint involved.
This spontaneous report was received from a physician via company representative regarding an 80 year old female patient. No pertinent medication history, drug reactions/allergies and concomitant medications were reported. On 06-JUL-2012, the patient was vaccinated with ZOSTAVAX, (lot and expiration date were unknown). On 17-OCT-2016, the patient developed a case of shingles. The patient sought medical attention to the physician and received unspecified treatment. The outcome of the event was unknown. The causality assessment was not provided by the reporter. No product quality complaint was filed. Additional information has been requested.
Shot hurt. Now have radiating pain down my arm. Cannot sleep on arm. Arm is weak.
bruising; skin painful on right leg to touch; headache; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruising), PAIN IN EXTREMITY (skin painful on right leg to touch) and HEADACHE (headache) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Depression, Anxiety and Seasonal allergy.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form once. On 20-Jul-2021, the patient experienced CONTUSION (bruising), PAIN IN EXTREMITY (skin painful on right leg to touch) and HEADACHE (headache). At the time of the report, CONTUSION (bruising), PAIN IN EXTREMITY (skin painful on right leg to touch) and HEADACHE (headache) had not resolved.            It was reported by the reporter that she experienced pain in leg right side. Concomitant medications were not reported by the reporter. Treatment information was not provided by the reporter.
Case receive Moderna bivalent dose on 09-14-22 in his left deltoid muscle using a 1 inch needle. 5 days later, he states he started getting a burning sensation at site; a "deep cutting" sensation that comes and goes; and is worse with certain movements of his arm. He states his wife has looked at site and not observed any abnormality. He has had no fever. He also stated that when he touches site, he has sensation but that he does not feel much in the way of a deeper sensation. He states that 40 years ago he had a torn muscle in this arm but that he has not felt anything like this with a previous shot. He has also noticed this same deep cutting sensation in both wrist and ankle area. He has history of fibromyalgia and is due to have low back surgery in November.
Right arm (deltoid) swelling, redness, heat. Went to ER received Medrol dose pack for reaction.
Patient described having facial numbness and droop along with increased drooling. Patient described as having a history of Bells Palsy and described side effects as similar.
Began to have urticarial rash within a couple of hours of receiving 4-year-old vaccines (DTaP, IPV, MMR, Varicella). Has been having sinus/ear infection for one week prior to receiving vaccines. Was given CLARITIN and Hydroxytine to treat infection. Say rash began on (R) though near site of DTaP/IPV injection.
Extremely sore arm at injection site for several days, fever of 99.8, fatigue. Also had some dizziness but not certain if caused by vaccine or by sinus problems. Took acetaminophen with some relief, rested. Slight soreness in right arm three days later.
PATIENT EXPERIENCED FATIGUE/FEVER (SATURDAY/SUNDAY After Vaccine administration) She WENT TO THE DOCTOR TUESDAY FOR ANNUAL CHECK UP AND THE DOCTOR SAW BREAK OUT OF HERPES IN NOSE, MOUTH, ON LIPS AND TONSILS BUT ONLY ON THE LEFT SIDE. Patient had EXTREME/SEVER HEADACH/PAIN IN NECK THAT CAUSED HER TO GO TO THE ER on Thursday AND THEY TOLD HER SHE WAS HAVING A Herpes Outbreak as a REACTION TO THE SHINGRIX VACCINE. SHE WAS GIVEN A SHOT OF TORADOL WHICH HELPED TREMENDOUSLY. Has BEEN ON VALTREX AND ADVIL. PATIENT IS STILL Fatigued BUT FEELING MUCH BETTER. NOT SURE IF HOSPITAL REPORTED THE ADR OR NOT. HAS NOT BEEN TO WORK SINCE. WAS TOLD BY ER DR.THAT THE REACTION WOULD LAST ABOUT 10 DAYS
approx 15min p/vax c/o entire arm & shoulder hurting, erythema @ site;approx quarter size;approx 30min p/vax c/o nausea & inc aching into back;sent to MD where exp inc dyspnea & diff w/swallowing;given adrenaline & antihistamine @ MD
myocardial/pericardial infection; myocardial/pericardial infection; some irregular heart beats; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE NUMBER UNKNOWN, SINGLE), for covid-19 immunization. The following information was reported: CARDIOMYOPATHY (medically significant), PERICARDIAL DISEASE (medically significant), outcome "unknown" and all described as "myocardial/pericardial infection"; HEART RATE IRREGULAR (non-serious), outcome "unknown", described as "some irregular heart beats". The patient underwent the following laboratory tests and procedures: Ejection fraction: dropping low after each rituximab treatment; 15%; 5% to 10%; Heart rate: irregular, notes: some irregular heart beats. Therapeutic measures were taken as a result of cardiomyopathy, pericardial disease, heart rate irregular. Clinical course: Caller asking if Ruxience was indicated for treatment of heart failure/low ejection fraction. Caller asking if Pfizer has any record of ejection fraction dropping significantly after treatment with Ruxience. Caller states he takes rituximab for cancer treatment but was not sure which branded product he uses. Caller states he experienced his ejection fraction dropping low after each treatment. Caller states he experienced a growth appear around his heart and aorta which grew from 2cm to 4cm in 2 to 3 weeks. Caller states he received immunotherapy in the hospital by the time it was 5cm. Caller states his ejection fraction dropped shortly after and was now only at 5% to 10%. Caller states his doctor did not seem concerned until it dropped to 15%. Caller states he also experienced cardiac side effects after taking 2 doses of the Pfizer BioNTech Covid-19 vaccine. Caller states he went to a specialist in Canada City and his study showed he had "some irregular heart beats and [myocardial/pericardial] infection." Caller states he took methotrexate for 3 months and "that took care of that."  Caller states, otherwise, his rituximab has "knocked the cancer back really quick and really well."  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.